Ipsen S.A. (EPA:IPN)
163.50
+3.10 (1.93%)
Apr 1, 2026, 11:24 AM CET
Ipsen Market Cap
Ipsen has a market cap or net worth of €13.17 billion as of April 1, 2026. Its market cap has increased by 42.68% in one year.
Market Cap
13.17B
Enterprise Value
12.61B
Revenue
3.93B
Ranking
n/a
PE Ratio
30.15
Stock Price
€163.50
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 13.17B, an increase of 641.49%. That is a compound annual growth rate of 10.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 12.81B | 31.09% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 99.01B |
| EssilorLuxottica Société anonyme | 89.91B |
| Sartorius Stedim Biotech | 16.05B |
| Eurofins Scientific SE | 10.92B |
| bioMérieux | 10.55B |
| ABIVAX Société Anonyme | 7.06B |
| Virbac | 2.92B |
| emeis Société anonyme | 2.00B |